会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • Methods for detecting and monitoring sleep disordered breathing using an implantable medical device
    • 使用可植入医疗装置检测和监测睡眠无序呼吸的方法
    • US20070073171A1
    • 2007-03-29
    • US11237354
    • 2005-09-28
    • Yong ChoTommy BennettBarbro Kjellstrom
    • Yong ChoTommy BennettBarbro Kjellstrom
    • A61B5/02
    • A61B5/042A61B5/0215A61B5/4818A61B5/7239
    • A method of identifying sleep disordered breathing (SDB) in a patient includes monitoring a hemodynamic pressure, deriving high, middle, and low values representative of the distribution of the hemodynamic pressure over a storage interval, measuring a ratio of a lower range to a full range of the hemodynamic pressure based on the derived high, middle, and low values, and using the ratio to determine whether the patient has experienced an SDB episode. Certain embodiments of the invention compare the ratio to a threshold value to identify the occurrence of an SDB episode, while other embodiments of the invention identify the occurrence of an SDB episode by monitoring for a simultaneous increase in both the ratio and the full range of the hemodynamic pressure. In certain other embodiments of the invention, activity level and/or duration criteria may be employed to confirm the occurrence of an SDB episode detected using the ratio.
    • 识别患者中睡眠呼吸障碍(SDB)的方法包括监测血液动力学压力,导出代表存储间隔内血流动力压力分布的高,中,低值,测量下限范围与满 基于导出的高,中,低值的血流动力压力范围,并使用该比例来确定患者是否经历SDB发作。 本发明的某些实施方案将比率与阈值进行比较以鉴定SDB发作的发生,而本发明的其它实施方案通过监测SDB发作的比例和全部范围的同时增加来识别SDB发作的发生 血流动力学压力。 在本发明的某些其他实施方案中,可以使用活动水平和/或持续时间标准来确认使用该比率检测到的SDB发作的发生。
    • 9. 发明申请
    • Apparatus and method for hemodynamic-based optimization of cardiac pacing
    • 心脏起搏血液动力学优化的装置和方法
    • US20050234517A1
    • 2005-10-20
    • US10629424
    • 2003-07-29
    • Frieder BraunschweigBarbro Kjellstrom
    • Frieder BraunschweigBarbro Kjellstrom
    • A61B5/0215A61N1/362A61N1/365A61N1/368A61N1/37A61N1/39A61N1/18A61B5/02A61N1/20A61N1/22A61N1/378
    • A61N1/3627A61N1/368A61N1/3682
    • The present invention demonstrates that continuous hemodynamic monitoring can be used to identify the optimal AV-delay in a pacemaker-treated patient with end stage heart failure. The AV-delay determines the timing of late diastolic filling in relation to the onset of ventricular contraction and the duration of diastolic filling. An optimal tuning of the AV-delay improves left ventricular filling pressures in patients with a DDD-programmed pacemaker and is particularly important in the presence of a compromised left ventricular function. It has been discovered that using the lowest ePAD pressure, an indirect parameter of the left ventricular end-diastolic pressure, as an indicator for the optimal AV interval. Importantly, measurements of the ePAD revealed the same optimal AV-delay as echocardiographic assessment of left ventricular diastolic filling by standard echocardiographic methods. Importantly, the HR determined as optimal during the acute hemodynamic test did not turn out to be optimal during daily living activities.
    • 本发明表明,连续血液动力学监测可用于鉴定起搏器治疗的终末期心力衰竭患者的最佳AV延迟。 AV延迟决定了舒张末期充盈的时间与心室收缩发作和舒张期充盈的时间有关。 AV延迟的最佳调整改​​善DDD程序起搏器患者的左心室充盈压,并且在存在左心室功能受损时特别重要。 已经发现,使用最低ePAD压力,左心室舒张末期压力的间接参数作为最佳AV间期的指标。 重要的是,ePAD的测量显示与通过标准超声心动图方法的左心室舒张期充盈的超声心动图评估相同的最佳AV延迟。 重要的是,在急性血液动力学测试期间确定为最佳的HR在日常生活活动中并不是最佳的。